Abbott Laboratories on Pace for Largest Percent Decrease Since October 2023 — Data Talk
Abbott Laboratories (ABT) is currently at $105.74, down $3.46 or 3.17%
--Would be lowest close since Dec. 8, 2023, when it closed at $104.51
--On pace for largest percent decrease since Oct. 11, 2023, when it fell 5.04%
--Currently down three of the past four days
--Down 6.96% month-to-date
--Down 3.93% year-to-date
--Down 25.25% from its all-time closing high of $141.46 on Dec. 27, 2021
--Down 5.83% from 52 weeks ago (April 19, 2023), when it closed at $112.29
--Down 12.58% from its 52-week closing high of $120.96 on March 8, 2024
--Up 17.25% from its 52-week closing low of $90.19 on Oct. 12, 2023
--Traded as low as $104.25; lowest intraday level since Dec. 11, 2023, when it hit $104.21
--Down 4.54% at today's intraday low; largest intraday percent decrease since March 15, 2024, when it fell as much as 5.54%
All data as of 10:38:45 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 17, 2024 10:55 ET (14:55 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks